GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BOM:500124) » Definitions » Sale Of Investment

Dr Reddy's Laboratories (BOM:500124) Sale Of Investment : ₹279,576 Mil (TTM As of Mar. 2025)


View and export this data going back to 1992. Start your Free Trial

What is Dr Reddy's Laboratories Sale Of Investment?

Dr Reddy's Laboratories's sale of investment for the three months ended in Mar. 2025 was ₹60,281 Mil. It means Dr Reddy's Laboratories gained ₹60,281 Mil from selling investments. Dr Reddy's Laboratories's sale of investment for the trailing twelve months (TTM) ended in Mar. 2025 was ₹279,576 Mil.

Compared with last quarter (₹56,307 Mil in Dec. 2024 ), Dr Reddy's Laboratories gained more money from selling investments in Mar. 2025 (₹60,281 Mil).

Dr Reddy's Laboratories Sale Of Investment Historical Data

The historical data trend for Dr Reddy's Laboratories's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dr Reddy's Laboratories Sale Of Investment Chart

Dr Reddy's Laboratories Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 79,528.00 77,771.00 112,805.00 129,784.00 279,576.00

Dr Reddy's Laboratories Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34,766.00 47,266.00 115,722.00 56,307.00 60,281.00

Dr Reddy's Laboratories Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹279,576 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dr Reddy's Laboratories Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Dr Reddy's Laboratories's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Dr Reddy's Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dr Reddy's Laboratories Ltd (BOM:500124) » Definitions » Sale Of Investment
Comparable Companies
BOM:500257 BOM:543904 BOM:532321 NSE:TORNTPHARM BOM:500087 NSE:AUROPHARMA BOM:500488 NSE:ALKEM BOM:532296 BOM:524494 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
RDY:USA DRREDDY:India RDDA:Germany RDDA:Germany R1DY34:Brazil
Address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, IND, 500 034
Website
https://www.drreddys.com
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Dr Reddy's Laboratories Headlines

No Headlines